Alli® weight loss products recalled by GlaxoSmithKline from US and Puerto Rico markets

GlaxoSmithKline (GSK) is voluntarily recalling all Alli® weight loss products from US and Puerto Rico market after tampering concerns. GSK has received inquiries from consumers in Alabama, Florida, Louisiana, Mississippi, New York, North Carolina and Texas about 20 bottles containing tablets and capsules that were not Alli®.

Alli® is a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat”. It is packaged in a labeled bottle that has an inner foil seal imprinted with the words: “Sealed for Your Protection.”

Some of the bottles are believed to contain a range of tablets and capsules of various shapes and colors that are not authenticated Alli®. Additionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic. These tampered products were purchased in retail stores. GSK spokesperson said that “Safety is our first priority and we are asking retailers and pharmacies to remove all alli from their shelves immediately”. The company is conducting an investigation and is working with the knowledge of the U.S. Food and Drug Administration (FDA) on this retailer level recall.